The EU Commission has approved the first CoV vaccines for babies and a preparation adapted to the omicron variants. The preparations from the manufacturers Pfizer and Biontech or Moderna may, in the future, be administered to babies from six months of age, as the commission decided today. In doing so, she followed a recommendation from the EU Medicines Agency (EMA).
Both vaccines are already approved for adults and children aged five and six, respectively. Doses for babies and young children are significantly lower.
Whether babies and children will actually be vaccinated against the coronavirus in the future is now a decision of the respective EU countries. According to the EMA experts, studies showed that even babies and young children were protected from infection with a very low dose.
At the same time, the EU Commission approved a Moderna vaccine adapted to two variants of Omicron. According to the EMA, the preparation is effective against the original coronavirus and the two subvariants BA.4 and BA.5. EMA experts recommend the adapted vaccine as a protective booster for people aged 12 and over. It is the second adapted Spikevax vaccine to be approved.